Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001520138-22-000512
Filing Date
2022-11-10
Accepted
2022-11-10 17:18:18
Documents
15

Document Format Files

Seq Description Document Type Size
1 S-1 bivi_s1.htm   iXBRL S-1 1207338
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM bivi_s1ex23z1.htm EX-23.1 2226
3 CALCULATION OF FILING FEE TABLES bivi_s1ex107.htm EX-FILING FEES 28778
  Complete submission text file 0001520138-22-000512.txt   1621762

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bivi-20220930.xsd EX-101.SCH 3477
5 XBRL DEFINITION FILE bivi-20220930_def.xml EX-101.DEF 26576
6 XBRL LABEL FILE bivi-20220930_lab.xml EX-101.LAB 36491
7 XBRL PRESENTATION FILE bivi-20220930_pre.xml EX-101.PRE 25231
9 EXTRACTED XBRL INSTANCE DOCUMENT bivi_s1_htm.xml XML 4445
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: S-1 | Act: 33 | File No.: 333-268313 | Film No.: 221378621
SIC: 2834 Pharmaceutical Preparations